Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FarmPhage
- Development stage
- Preclinical
- Lead developer
- Cytophage Technologies
- Administration
- Oral
01
Overview
FarmPhage is a line of bacteriophage-based products developed by Cytophage Technologies to manage and treat bacterial infections in livestock. The products contain specific bacteriophages that target and kill pathogenic bacteria, including *Escherichia coli*, *Salmonella*, and *Shigella*, through phage-mediated bacterial lysis. FarmPhage is designed to promote animal growth, enhance gut health, and reduce mortality rates, serving as a non-antibiotic alternative for livestock producers. The product line includes specific formulations such as AviPhage for poultry health and OvaPhage for egg production, available in water-soluble solutions and lyophilized tablets.
- Brand names
- FarmPhageAviPhageOvaPhageBoviPhagePhageFend
Beyond the preview
Go deeper on FarmPhage.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FarmPhage.